.Atea Pharmaceuticals' antiviral has neglected an additional COVID-19 test, but the biotech still ke...
.Neurocrine Biosciences' schizophrenia plan pivot has stopped working. The biotech was actually not ...
.Sanofi has actually made an overdue entrance to the radioligand event, spending 100 million euros (...
.After F2G's initial try to get a new lesson of antifungal to market was thwarted due to the FDA, th...
.Moderna has actually sworn to cut R&D spending through $1.1 billion by 2027. The selection to re...
.Simply 4 months after Sanofi bet $80 million in beforehand money on Fulcrum Rehabs' losmapimod, the...
.Cancer cells company Oncternal Therapies is folding all its own clinical tests and laying off perso...
.Roche is keeping out hopes that its own injectable excessive weight prospect might eventually demon...
.Novo Nordisk has actually elevated the lid on a phase 1 test of its dental amylin and also GLP-1 re...
.Just a couple of brief weeks after gaining an FDA Fast lane tag for its own investigational BTK deg...